BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 22374425)

  • 1. Expression of EphrinB2 and EphB4 in glioma tissues correlated to the progression of glioma and the prognosis of glioblastoma patients.
    Tu Y; He S; Fu J; Li G; Xu R; Lu H; Deng J
    Clin Transl Oncol; 2012 Mar; 14(3):214-20. PubMed ID: 22374425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Detecting protein expression of EphrinB2 ligand and its receptor EphB4 in astrocytoma using confocal laser scanning microscopy].
    Xiao HL; Bian XW; Li ZP; Long ZY; Wang D
    Ai Zheng; 2004 Oct; 23(10):1161-5. PubMed ID: 15473927
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coexpression of EphB4 and ephrinB2 in tumour advancement of ovarian cancers.
    Alam SM; Fujimoto J; Jahan I; Sato E; Tamaya T
    Br J Cancer; 2008 Feb; 98(4):845-51. PubMed ID: 18231102
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coexpression of EphB4 and ephrinB2 in tumor advancement of uterine cervical cancers.
    Alam SM; Fujimoto J; Jahan I; Sato E; Tamaya T
    Gynecol Oncol; 2009 Jul; 114(1):84-8. PubMed ID: 19356789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of ephrinB2 and EphB4 in tumor advancement of uterine endometrial cancers.
    Alam SM; Fujimoto J; Jahan I; Sato E; Tamaya T
    Ann Oncol; 2007 Mar; 18(3):485-90. PubMed ID: 17108150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EphrinB2-EphB4 Signaling in Neurooncological Disease.
    Piffko A; Uhl C; Vajkoczy P; Czabanka M; Broggini T
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of ephrinB2 signaling on proliferation and invasion in glioblastoma multiforme.
    Bhatia S; Bukkapatnam S; Van Court B; Phan A; Oweida A; Gadwa J; Mueller AC; Piper M; Darragh L; Nguyen D; Gilani A; Knitz M; Bickett T; Green A; Venkataraman S; Vibhakar R; Cittelly D; Karam SD
    Mol Carcinog; 2020 Sep; 59(9):1064-1075. PubMed ID: 32567728
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The significance of EphB4 and EphrinB2 expression and survival in head and neck squamous cell carcinoma.
    Yavrouian EJ; Sinha UK; Rice DH; Salam MT; Gill PS; Masood R
    Arch Otolaryngol Head Neck Surg; 2008 Sep; 134(9):985-91. PubMed ID: 18794445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Relationship between multi-slice spiral CT pulmonary perfusion imaging and the expression of EphB4 and ephrinB2 in non-small cell lung cancer].
    Xiong Z; Liu JK; Zhou ML; Hu CP; Zhou H; Chen W
    Zhonghua Zhong Liu Za Zhi; 2011 Mar; 33(3):192-6. PubMed ID: 21575518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EphrinB2 and EphB4 expression in pterygia: new insights and preliminary results.
    Xue C; Huang Z; Wang J; Dong Y; Zhou X
    Can J Ophthalmol; 2009 Apr; 44(2):185-8. PubMed ID: 19491953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ephrin‑B2 inhibits cell proliferation and motility in vitro and predicts longer metastasis‑free survival in breast cancer.
    Magic Z; Sandström J; Perez-Tenorio G
    Int J Oncol; 2019 Dec; 55(6):1275-1286. PubMed ID: 31638179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dysregulation of the EphrinB2-EphB4 ratio in pediatric cerebral arteriovenous malformations is associated with endothelial cell dysfunction in vitro and functions as a novel noninvasive biomarker in patients.
    Fehnel KP; Penn DL; Duggins-Warf M; Gruber M; Pineda S; Sesen J; Moses-Gardner A; Shah N; Driscoll J; Zurakowski D; Orbach DB; Smith ER
    Exp Mol Med; 2020 Apr; 52(4):658-671. PubMed ID: 32286515
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of EphB4, EphrinB2, and epidermal growth factor receptor in papillary thyroid carcinoma: A pilot study.
    Sharma GK; Dhillon VK; Masood R; Maceri DR
    Head Neck; 2015 Jul; 37(7):964-9. PubMed ID: 24634162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ligand-dependent EphB4 activation serves as an anchoring signal in glioma cells.
    Kawahara Y; Furuta T; Sabit H; Tamai S; Dong Y; Jiapaer S; Zhang J; Zhang G; Oishi M; Miyashita K; Hayashi Y; Nakada M
    Cancer Lett; 2019 May; 449():56-65. PubMed ID: 30776480
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mammalian target of rapamycin signaling pathway contributes to glioma progression and patients' prognosis.
    Yang J; Liao D; Wang Z; Liu F; Wu G
    J Surg Res; 2011 Jun; 168(1):97-102. PubMed ID: 20036387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The ephrinB2/EphB4 axis is dysregulated in osteoprogenitors from myeloma patients and its activation affects myeloma bone disease and tumor growth.
    Pennisi A; Ling W; Li X; Khan S; Shaughnessy JD; Barlogie B; Yaccoby S
    Blood; 2009 Aug; 114(9):1803-12. PubMed ID: 19597185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ephrin B2/EphB4 pathway in hepatic stellate cells stimulates Erk-dependent VEGF production and sinusoidal endothelial cell recruitment.
    Das A; Shergill U; Thakur L; Sinha S; Urrutia R; Mukhopadhyay D; Shah VH
    Am J Physiol Gastrointest Liver Physiol; 2010 Jun; 298(6):G908-15. PubMed ID: 20338920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low concentrations of TNF-α promote osteogenic differentiation via activation of the ephrinB2-EphB4 signalling pathway.
    Wang L; Zhang J; Wang C; Qi Y; Du M; Liu W; Yang C; Yang P
    Cell Prolif; 2017 Feb; 50(1):. PubMed ID: 27726217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Hedgehog signalling pathway and its prognostic impact in human gliomas.
    Li Q; Zhang Y; Zhan H; Yuan Z; Lu P; Zhan L; Xu W
    ANZ J Surg; 2011 Jun; 81(6):440-5. PubMed ID: 22295347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distribution of EphB4 and EphrinB2 in normal and malignant urogenital tissue.
    Ozgür E; Heidenreich A; Dagtekin O; Engelmann U; Bloch W
    Urol Oncol; 2011; 29(1):78-84. PubMed ID: 19272799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.